Proactively offering Quitline counselling and nicotine replacement therapy can reduce the prevalence of smoking
The Australian Institute of Health and Welfare has identified tobacco smoking as the leading cause of preventable disease and death in Australia, and 11% of people over 14 years of age reported smoking daily in 2019.1 Public health measures, such as public smoking bans, anti‐smoking media campaigns, and high tobacco taxes, have encouraged people to stop smoking, but most quit attempts are unsuccessful. The most effective approach to smoking cessation is a combination of pharmacological and behavioural support, such as nicotine replacement therapy (NRT) with Quitline telephone counselling.2 Quitlines are an evidence‐based, readily accessible, and cost‐effective public health intervention.3 However, fewer than 2% of Australians who smoke used a Quitline service during 2019.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019 (Cat. no. PHE 270). 16 July 2020. https://www.aihw.gov.au/reports/illicit‐use‐of‐drugs/national‐drug‐strategy‐household‐survey‐2019 (viewed Feb 2022).
- 2. Das S, Prochaska JJ. Innovative approaches to support smoking cessation for individuals with mental illness and co‐occurring substance use disorders. Expert Rev Respir Med 2017; 11: 841‐850.
- 3. Matkin W, Ordóñez‐Mena JM, Hartmann‐Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2019; 5: CD002850.
- 4. Webb AR, Coward L, Meanger D, et al. Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial. Med J Aust 2022; 216: 357‐363.
- 5. Dickerson F, Schroeder J, Katsafanas E, et al. Cigarette smoking by patients with serious mental illness, 1999–2016: an increasing disparity. Psychiatr Serv 2018; 69: 147‐153.
- 6. Hartz SM, Pato CN, Medeiros H, et al; Genomic Psychiatry Cohort Consortium. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 2014; 71: 248‐254.
- 7. Sharma R, Gartner CE, Hall WD. The challenge of reducing smoking in people with serious mental illness. Lancet Respir Med 2016; 4: 835‐844.
- 8. Plever S, McCarthy I, Anzolin, M, et al. Queensland smoking care in adult acute mental health inpatient units: supporting practice change. Aust N Z J Psychiatry 2020; 54: 919‐927.
- 9. Khan A, Green K, Khandaker G, et al. The impact of a regional smoking cessation program on referrals and use of Quitline services in Queensland, Australia: a controlled interrupted time series analysis. Lancet Reg Health West Pac 2021; 14: 100210.
Coral Gartner holds a National Health and Medical Research Council research grant (GNT1198301).
No relevant disclosures.